China SFDA Mulls Preferential Treatment For Makers Of Pediatric Drugs
This article was originally published in PharmAsia News
Executive Summary
China's State FDA is considering providing easier market access to makers of drugs aimed at children as one way to promote a type of drug mostly non-existent in the country.